- •Corneal Disease
- •Preface
- •Contents
- •Contributors
- •Core Messages
- •Organisms
- •Detection
- •Acid Fast Smears
- •Culture Media
- •Molecular Tests
- •Nucleic Acid Hybridization Probes
- •Line Probes
- •DNA Sequencing
- •FISH (Fluorescent In Situ Hybridization) Assay
- •DNA Microarray
- •Pulse Field Gel Electrophoresis (PFGE)
- •Management
- •Clinical Diagnosis
- •Medical Therapy
- •Surgical Intervention
- •Penetrating Keratoplasty
- •Corneal Cross-Linking
- •Summary for the Clinician
- •References
- •Core Messages
- •Introduction
- •Epidemiology
- •Visual Morbidity
- •Documentation
- •Causative Factors
- •Causative Bacteria
- •Investigation of Keratitis
- •Laboratory Diagnosis: Susceptibility Testing
- •Susceptibility and Resistance of Bacterial Isolates
- •Treatment: Antimicrobials
- •Current Antimicrobials in Use
- •The Fluoroquinolones
- •Aminoglycosides
- •Cephalosporins
- •Other Antimicrobials Used
- •Development of Existing and New Classes of Drugs
- •Tigecycline
- •Linezolid
- •Meropenem
- •Combination Therapy
- •Drug Delivery to the Cornea
- •Novel Methods of Drug Delivery to the Cornea
- •Conclusion
- •References
- •3: Heredity of Keratoconus
- •Introduction
- •Is Keratoconus a Heritable or Genetic Disease?
- •Mutational Screening of Candidate Genes in Keratoconus
- •Visual System Homeobox Gene 1 (VSX1)
- •Superoxide Dismutase 1 (SOD1)
- •Interleukin 1 (IL1) Superfamily
- •Collagen Genes
- •Genetic Mapping in Keratoconus
- •Genetics of Keratoconus – Mendelian or Complex?
- •References
- •4: Advance in Corneal Imaging
- •Introduction
- •In Vivo Confocal Microscopy (IVCM)
- •Principles of Confocal Microscopy
- •The Normal Cornea
- •Clinical Applications
- •Infectious Keratitis
- •Corneal Dystrophies
- •Refractive Surgery
- •Corneal Surgery
- •Other Clinical Applications
- •Limitations of IVCM
- •Anterior Segment Ocular Coherence Tomography (OCT)
- •Clinical Applications
- •Corneal Thickness Assessment
- •Refractive Surgery
- •Corneal Grafts
- •Limitations
- •Conclusion
- •References
- •Core Messages
- •Introduction
- •“Angiogenic Privilege of the Cornea” or “How Does the Normal Corneal Maintain Its Avascularity?”
- •General Mechanisms
- •Corneal Hemangiogenesis After Low-Risk Keratoplasty
- •Corneal Hemangiogenesis After High-Risk Keratoplasty
- •Corneal Lymphangiogenesis: Essential for Corneal Graft Rejection
- •Corneal Lymphangiogenesis in Dry Eye
- •Imaging of Corneal Lymphatic Vessels
- •Novel Anti(lymph)Angiogenic Treatment Options at the Cornea
- •Current Treatment Options for Immature Corneal (Blood and Lymphatic) Vessels
- •Steroids
- •Anti-VEGFs (Bevazicumab, Ranibuzumab, Pegaptanib, VEGF Trap)
- •Anti-IRS 1-Strategies (Antisense Oligonucleotides Against IRS 1)
- •Treatment Options for Mature Corneal Vessels
- •Unmet Needs and Future Directions
- •References
- •Core Messages
- •Introduction
- •Retrieval of Donor Tissue
- •Technical Aspects
- •Microbiological Aspects
- •Tissue Evaluation Aspects
- •Corneal Storage
- •Moist Chamber Storage of the Donor Eye
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Hypothermic Storage of the Corneoscleral Button
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Organ Culture (Normothermic Storage) of the Corneoscleral Button
- •Technical Aspects
- •Storage Period
- •Microbiological Safety
- •Tissue Evaluation
- •Other Aspects
- •Pre-cutting of Corneal Tissue for Endothelial Keratoplasty (EK)
- •Microkeratome Cutting
- •Femtosecond Laser Cutting
- •Stripping of Descemet’s Membrane with Endothelium
- •Donor Considerations for EK
- •References
- •7: Infant Keratoplasty
- •Core Messages
- •Introduction
- •Indications for Surgery
- •Visual Outcome
- •Patient Selection
- •Patient Assessment
- •Ancillary Testing
- •Donor Tissue
- •Intraoperative Considerations
- •Concurrent Surgical Procedures
- •Postoperative Considerations
- •Suture Management
- •Optical Correction and Amblyopia Therapy
- •Postoperative Complications
- •Glaucoma
- •Graft Rejection
- •Graft Failure
- •Alternatives to Penetrating Keratoplasty
- •Conclusion
- •References
- •Index
6 Storage of Donor Cornea for Penetrating and Lamellar Transplantation |
93 |
|
|
Today, eye banking services are provided in an environment of stringent quality assurance standards, often with increasing government regulation or oversight. All of these systems have as their basis the identification and minimisation of risk so as to ensure and improve the quality and safety of transplanted tissue. Quality management systems and risk assessment have become important aspects of eye banking where the emphasis is now not only on quantity of tissue provided but also where quality of tissue and quality of service have become priorities.
Different recovery procedures, storage techniques, and in more recent years tissue processing techniques, have been introduced and each have their own benefits and risks. These will be compared in this chapter. However, the adoption or choice of a particular procedure needs to be considered within the context of a practitioner’s local conditions to ensure an efficient, safe and quality service. Ultimately, the objective of eye banking remains – the delivery of ocular tissue, donated for transplantation, in order to allow the ophthalmic surgeon to restore sight in a safe and high-quality procedure.
Retrieval of Donor Tissue
Either the corneoscleral button is removed in situ and directly transferred to a storage or collection solution, or the eye is enucleated and the corneoscleral button excised later in the eye bank laboratory. Legal requirements will vary between jurisdictions, with some legislature requiring that only medical practitioners be authorised to perform the donor procedure, and still some others specifying that only in situ excision rather than enucleation be allowed. The suggested procedures for enucleation and in situ excision are described in the Medical and Technical Standards of many eye banks and eye banking organisations. Ultimately, the preferred method is dependent on local/national conditions and considerations and legalities but the persons performing the donor surgery must use their professional judgment and satisfy themselves that all reasonable steps and normal surgical precautions have been taken to minimise contamination or damage to the tissue.
Technical Aspects
The benefits and risks of both procedures are summarised in Table 6.1. In situ excision is more technically demanding and also requires the time to perform a careful in situ examination by penlight or handheld slit lamp. The introduction of the artificial anterior chamber also means that lamellar surgical techniques can be performed on the corneoscleral button obviating need for a whole eye. The enucleation procedure is more invasive with the risk of haemorrhages from the optic vessels and the orbit affecting the appearance of the donor, although this is not a common problem [4].
Upon the death of the donor, the corneal endothelium is subject to warm ischemia and is in contact with stagnant aqueous humour. This results in progressive cytolysis and cell death and this may also progress during subsequent storage.
94 |
|
|
E. Pels and G. Pollock |
|
|
|
|
Table 6.1 Tissue retrieval considerations |
|
|
|
Factors to consider |
|
In situ excision |
Enucleation |
Legal provisions |
|
Tissue removal |
Organ removal |
Technical procedure |
Staff |
Medical/technical trained |
Trained |
|
Time |
Longer |
Shorter |
|
Risk |
Less invasive |
Risk of haemorrhage |
Eye bank facility |
|
Not necessary |
Laboratory |
Contamination rate |
|
Similar to higher in organ |
|
|
|
culture |
|
Tissue evaluation |
|
Pen light, slit lamp |
Slit lamp |
Inspection anterior chamber |
|
Pen light |
Slit lamp |
Tissue viability |
|
Similar or better due to |
|
|
|
shorter delay |
|
|
|
expiration–excision |
|
Limiting the time between the cessation of donor circulation and storage of the cornea results in a more viable endothelium, but an absolute acceptable time interval has not yet been defined. Recommended death to enucleation times for corneas intended for organ culture storage tend to be more liberal than those for hypothermic storage. The normothermic temperatures of organ culture storage provide for an in-built viability assay on the “health” of the cornea, and evaluation at the end of the storage period allows for a discard of those corneas they may have suffered from ischaemic damage following the donor’s death. A period of 24 h (or beyond) death to enucleation is often a recommended benchmark. Conversely, hypothermic storage doesn’t provide for this type of assessment and thus more conservative maximum death to enucleation times of 12–18 h are often used as a benchmark.
Microbiological Aspects
The normal ocular flora that is present during life multiplies with the lack of lid movement and lyzosomal enzymes in the tear film. Before removal of the tissue, bacterial contamination from both exogenous sources and from the ocular flora post-mortem [5] has to be removed. For in situ excision, one must be especially aware of the bacteriologic considerations, as no further decontamination of the tissue is possible. In general, the procedure consists of vigorous rinsing with balanced salt solution, moistening of the eye and eye lashes with a broad-spectrum antibiotic/ antifungal solution and disinfection of the lids and the surrounding eye tissue and skin with povidone–iodine solution. In the case of enucleation, many eye banks will forego extensive donor preparation, opting instead to decontaminate the globe within the laboratory. This is usually done by vigorous rinsing with a balanced salt solution, immersion of the eye in a 0.5–1% povidone–iodine solution, followed by a subsequent rinse with balanced salt (See technical guidelines EBAA, EBAANZ and EEBA). Comparative studies support the validity of both procedures [5].
The overall rate of post-operative endophthalmitis following penetrating keratoplasty has been found to be around 0.4% in a literature review of 90,549 cases [6].
